#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vascular malformation Transient ischaemic attack Hepatic cirrhosis Cholestatic pruritus Choroid melanoma Bladder cancer Colorectal cancer metastatic Cystic fibrosis Chorioretinitis Ovarian cancer Bile acid synthesis disorder Subarachnoid haemorrhage Acquired haemophilia Amyloidosis Liver transplant rejection More trials…

    Learn about Rare Diseases

    Glycogen storage disease type V – Treatment Waldenstrom’s macroglobulinaemia recurrent – Basic Information Phenylketonuria – Trials in Disease Breast angiosarcoma metastatic – Treatment Bronchiolitis obliterans syndrome – Basic Information Chondrosarcoma metastatic – Diagnostics Langerhans cell sarcoma – Basic Information Haemophilia – Treatment Alagille syndrome – Diagnostics Rett syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dmd06-Mab Cln-081 Glycerol Antiemetics And Antinauseants Naloxone Tulisokibart Cendakimab Adrenaline Acid Tartrate Bp Edg-5506 Cimetidine Hydrochloride Hydroxyzine Hydrochloride Levobupivacaine Hydrochloride Ep0031 Atezolizumab Diazepam A49 Garadacimab Evg321 Iptacopan Neratinib More therapies…

    Learn about Your Condition

    Small fibre neuropathy Pneumonia chlamydial Back pain Noninfective chorioretinitis Myositis Embolism venous ROHHAD syndrome Psychological trauma Supraventricular tachycardia Anal cancer stage III Lymphocyte adoptive therapy Dementia Deafness traumatic Neuroendocrine carcinoma Chordoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Wojewodzki Szpital Specjalistyczny W Bialej Podlaskiej…

Wojewodzki Szpital Specjalistyczny W Bialej Podlaskiej

Ul. Terebelska 57/65, Biala Podlaska, 21-500, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Cabozantinib, Nivolumab, and Ipilimumab for Patients with Advanced or Metastatic Kidney Cancer Who Have Not Received Prior Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Renal cancer metastatic
    Investigated Drugs:
    • Cabozantinib
    • Ipilimumab
    • Nivolumab
    Belgium Czechia Finland France Germany Italy +3

  • Study Comparing Tivozanib and Nivolumab Combination to Tivozanib Alone in Patients with Renal Cell Carcinoma After Previous Immune Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    Investigated Drugs:
    • Nivolumab
    • Tivozanib
    Belgium Czechia France Germany Italy Poland +2
Previous Page
1 2 3 4

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!